57. Antifungal Agents for Pediatric Transplant Recipients

  1. Deepali Kumar MD, MSc, FRCPC and
  2. Atul Humar MD, MSc, FRCPC
  1. Lara Danziger-Isakov MD, MPH1,2,
  2. Lizbeth Hansen2 and
  3. Elizabeth Neuner PharmD, BCPS3

Published Online: 5 MAY 2011

DOI: 10.1002/9781444397949.ch57

The AST Handbook of Transplant Infections

The AST Handbook of Transplant Infections

How to Cite

Danziger-Isakov, L., Hansen, L. and Neuner, E. (2011) Antifungal Agents for Pediatric Transplant Recipients, in The AST Handbook of Transplant Infections (eds D. Kumar and A. Humar), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444397949.ch57

Editor Information

  1. Transplant Infectious Diseases, University of Alberta, Edmonton, Canada

Author Information

  1. 1

    Center for Pediatric Infectious Diseases, The Children's Hospital at Cleveland Clinic, Cleveland, OH, USA

  2. 2

    Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland, OH, USA

  3. 3

    Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA

Publication History

  1. Published Online: 5 MAY 2011
  2. Published Print: 13 MAY 2011

ISBN Information

Print ISBN: 9780470658277

Online ISBN: 9781444397949

SEARCH

Keywords:

  • antifungal agents - for pediatric transplant recipients;
  • antifungals class;
  • triazoles, itraconazole - histoplasmosis, blastomycosis, coccidiodomycosis;
  • benzodiazepines - contraindicated with alprazolam;
  • voriconazole - aspergillus, scedosporium, fusarium;
  • interacting drug and effect;
  • fluconazole candidasis - cryptococcosis;
  • posaconazole - posaconazole absorption, increased when given with high-fat meals;
  • echinocandins - caspofungin;
  • micafungin candidasis and aspergillosis